Eli Lilly
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Eli Lilly is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Eli Lilly embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportBoard Bias
Expand Summary
CEO of Eli Lilly
David A. Ricks
Summary:
Headquartered in Indianapolis, Indiana, Eli Lilly is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. David A. Ricks serves as CEO/President and Chairman, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $385,250 to Republican causes and $113,137 to Democratic causes. Under their tenure, Eli Lilly currently holds a 'High Risk' risk rating.
View Full Board Bias ReportPolitical Contributions of Leadership:
$385,250
$113,137
Republican
Democrat
Shareholder Proposals
Expand Summary
| Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
|---|---|---|---|---|---|
| 5/6/24 | CommonSpirit Health | Adoption of a human rights policy | Against | N/A | |
| 5/6/24 | John Chevedden | Eliminate Supermajority Voting Requirements | Against | N/A | |
| 5/6/24 | Trinity Health | Report on Impact of Patent Process on Product Access | Against | N/A | |
| 5/6/24 | As You Sow on behalf of Marguerite Casey Foundation | Report on the Effectiveness of the Company's Diversity, Equity, and Inclusion Efforts | Against | N/A | |
| 5/6/24 | SEIU Master Trust | Disclosing Lobbying Activity | Against | N/A | |
| 5/1/23 | Governance | CommonSpirit Health | Report on Lobbying Values Congruency | Against | 22.50% |
| 5/1/23 | Social | National Center for Public Policy | Report on Risks of Supporting Abortion | Against | 1.90% |
| 5/1/23 | Governance | Change Finance | Require Indirect Political Spending Reporting | Against | 4.10% |
| 5/1/23 | Social | Trinity Health | Report on Impact of Patent Process on Product Access | Against | 10.40% |
| 5/1/23 | Governance | John Chevedden | Eliminate Supermajority Voting Requirements | Against | 40.70% |
| 5/1/23 | Social | As You Sow, on behalf of Leslie Oelsner Bene IRA of S Berman (S), Sarah B Sonnenfeld Rev Tr (S), Curtis Overway and Marcelina Cravat-Overway | Greater Disclosure of Material Corporate Diversity | Against | 27.10% |
| 5/1/23 | Social | As You Sow | Report on the Effectiveness of the Company's Diversity, Equity, and Inclusion Efforts | Against | 27.10% |
| 5/1/23 | Governance | SEIU Master Trust | Report Disclosing Lobbying Activity | Against | 31.40% |
| 5/2/22 | Governance | Trinity Health | Report Oversight of Risks Related to Anticompetitive Pricing Strategies | Against | 22.78% |
| 5/2/22 | Social | CommonSpirit Health | Disclose Lobbying Activities & Alignment with Public Policy Positions | Against | 34.00% |
| 5/2/22 | Governance | Legal & General Invest. Mgmt. America, Inc. | Independent Board Chair | Against | 34.54% |
| 5/2/22 | Social | SEIU Master Trust | Report on Lobbying Payments and Policy | Against | 37.03% |